|Harvard University, BA|
|Harvard Business School, MBA|
Bob has more than twenty-five years of experience in venture capital and has served as a director of many public and private companies. He is a former director of the National Venture Capital Association and President of the New England Venture Capital Association. In addition, Bob has been recognized by the prestigious Forbes Midas List as one of the top venture capitalists in the industry, and has earned the 2008 HBS Healthcare Alumni Achievement Award.
Background Bob has been an investor in many successful healthcare service, medical device and biotechnology companies. Some of the services companies he has backed are Community Health Systems (NYSE: CYH), Mariner Health Group (IPO/acquired), New England Critical Care (IPO/acquired), Renal Treatment Centers (IPO/acquired) and U.S. Labs (acquired). Bob’s medical technology investments include AVEO Pharmaceuticals, Codon Devices, Conor Medsystems (IPO/acquired), Generation Health, Helicos BioSciences (Nasdaq: HLCS), iZumi, Mitotix (Neuer Market: GPC Biotech AG), Origin Medsystems (acquired), PerSeptive Biosystems (IPO/acquired), Pervasis Therapeutics, PRAECIS PHARMACEUTICALS (Nasdaq: PRCS) and RedBrick Health. Before co-founding Highland, Bob was a general partner at a Boston-based venture capital partnership. Immediately prior to entering venture capital, he spent four years as the Executive Director of the John A. Hartford Foundation. He also was the Chief Executive of the Clark Foundation and the Burden Foundation. Bob is a former Assistant to the U.S. Secretary of Commerce and an Assistant to the head of the international division of the U.S. Treasury.